Karen Anthony

2.4k total citations · 1 hit paper
31 papers, 1.7k citations indexed

About

Karen Anthony is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Karen Anthony has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 7 papers in Genetics and 5 papers in Physiology. Recurrent topics in Karen Anthony's work include Muscle Physiology and Disorders (15 papers), RNA Research and Splicing (7 papers) and RNA Interference and Gene Delivery (6 papers). Karen Anthony is often cited by papers focused on Muscle Physiology and Disorders (15 papers), RNA Research and Splicing (7 papers) and RNA Interference and Gene Delivery (6 papers). Karen Anthony collaborates with scholars based in United Kingdom, United States and France. Karen Anthony's co-authors include Jennifer E. Morgan, Francesco Muntoni, Virginia Arechavala‐Gomeza, Lucy Feng, Sebahattin Çirak, Silvia Torelli, Caroline A. Sewry, Jean‐Marc Gallo, Volker Straub and Michela Guglieri and has published in prestigious journals such as The Lancet, PLoS ONE and Brain.

In The Last Decade

Karen Anthony

28 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

2011 656 citations Sebahattin Çirak, Virginia Arechavala‐Gomeza et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen Anthony United Kingdom	16	1.4k	340	272	256	208	31	1.7k
Gabriella Restagno Italy	28	1.1k 0.8×	701 2.1×	238 0.9×	305 1.2×	133 0.6×	81	2.5k
M. Mayer France	21	1.0k 0.8×	333 1.0×	135 0.5×	152 0.6×	153 0.7×	49	1.5k
Luca Bello Italy	21	1.0k 0.7×	285 0.8×	219 0.8×	136 0.5×	249 1.2×	84	1.4k
Marc Bartoli France	32	2.3k 1.7×	333 1.0×	347 1.3×	488 1.9×	428 2.1×	89	2.8k
Manuela Corti United States	19	995 0.7×	169 0.5×	360 1.3×	693 2.7×	138 0.7×	48	1.8k
Raffaella Adami Italy	17	996 0.7×	233 0.7×	254 0.9×	111 0.4×	142 0.7×	39	1.4k
María Morell Spain	21	875 0.6×	150 0.4×	117 0.4×	256 1.0×	36 0.2×	31	1.7k
Hannah G. Radley‐Crabb Australia	22	1.3k 1.0×	166 0.5×	597 2.2×	86 0.3×	164 0.8×	28	1.8k
Delphine Bohl France	26	1.4k 1.0×	225 0.7×	375 1.4×	927 3.6×	95 0.5×	52	2.5k
Zhen‐Ning Zhang China	20	1.8k 1.3×	207 0.6×	483 1.8×	186 0.7×	92 0.4×	49	2.6k

Countries citing papers authored by Karen Anthony

Since Specialization

Citations

This map shows the geographic impact of Karen Anthony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Anthony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Anthony more than expected).

Fields of papers citing papers by Karen Anthony

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Anthony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Anthony. The network helps show where Karen Anthony may publish in the future.

Co-authorship network of co-authors of Karen Anthony

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Anthony. A scholar is included among the top collaborators of Karen Anthony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Anthony. Karen Anthony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anthony, Karen, et al.. (2025). 89P Duchenne muscular dystrophy gene product expression is associated with survival in sarcoma. ESMO Open. 10. 104402–104402.

Collins, Luke, et al.. (2025). Duchenne muscular dystrophy gene product expression is associated with survival in head and neck squamous cell carcinoma. Scientific Reports. 15(1). 10754–10754.

Guo, Jing & Karen Anthony. (2023). A systematic literature review and meta-analysis of the effectiveness of vitamin D supplementation for patients with Duchenne muscular dystrophy. Neuromuscular Disorders. 33(11). 835–844. 2 indexed citations

Machado, Lee R., et al.. (2022). A Survey of Machine Learning Approaches Applied to Gene Expression Analysis for Cancer Prediction. IEEE Access. 10. 27522–27534. 49 indexed citations

D’souza, Darwin, et al.. (2022). Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma. Scientific Reports. 12(1). 3200–3200. 6 indexed citations

Machado, Lee R., et al.. (2020). The Duchenne muscular dystrophy gene and cancer. Cellular Oncology. 44(1). 19–32. 24 indexed citations

Anthony, Karen, et al.. (2019). Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy. Molecular Neurobiology. 57(3). 1748–1767. 90 indexed citations

Hiller, Monika, Maria Sofia Falzarano, Iker García, et al.. (2018). A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures. PLoS ONE. 13(10). e0204485–e0204485. 16 indexed citations

Zhou, Haiyan, Narinder Janghra, Chalermchai Mitrpant, et al.. (2013). A Novel Morpholino Oligomer Targeting ISS-N1 Improves Rescue of Severe Spinal Muscular Atrophy Transgenic Mice. Human Gene Therapy. 24(3). 331–342. 100 indexed citations

10.

Arechavala‐Gomeza, Virginia, Karen Anthony, Jennifer E. Morgan, & Francesco Muntoni. (2012). Antisense Oligonucleotide-Mediated Exon Skipping for Duchenne Muscular Dystrophy: Progress and Challenges. Current Gene Therapy. 12(3). 152–160. 66 indexed citations

11.

Anthony, Karen, Lucy Feng, Virginia Arechavala‐Gomeza, et al.. (2012). Exon Skipping Quantification by Quantitative Reverse-Transcription Polymerase Chain Reaction in Duchenne Muscular Dystrophy Patients Treated with the Antisense Oligomer Eteplirsen. Human Gene Therapy Methods. 23(5). 336–345. 33 indexed citations

12.

Çirak, Sebahattin, Virginia Arechavala‐Gomeza, Michela Guglieri, et al.. (2011). Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. The Lancet. 378(9791). 595–605. 656 indexed citations breakdown →

13.

Anthony, Karen, Sebahattin Çirak, Silvia Torelli, et al.. (2011). Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials. Brain. 134(12). 3547–3559. 112 indexed citations

14.

Çirak, Sebahattin, Lucy Feng, Karen Anthony, et al.. (2011). Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy. Molecular Therapy. 20(2). 462–467. 90 indexed citations

15.

Çirak, Sebahattin, Virginia Arechavala‐Gomeza, Michela Guglieri, et al.. (2011). P03 Exon skipping and dystrophin restoration in Duchenne muscular dystrophy patients after systemic phosphorodiamidate morpholino oligomer treatment. Neuromuscular Disorders. 21. S7–S8. 1 indexed citations

16.

Anthony, Karen & Jean‐Marc Gallo. (2010). Aberrant RNA processing events in neurological disorders. Brain Research. 1338. 67–77. 67 indexed citations

17.

Rodríguez-Martín, Teresa, Karen Anthony, Mariano A. García-Blanco, et al.. (2009). Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing. Human Molecular Genetics. 18(17). 3266–3273. 46 indexed citations

18.

Chapple, J. Paul, Karen Anthony, Thomas R. Martin, et al.. (2007). Expression, localization and tau exon 10 splicing activity of the brain RNA-binding protein TNRC4. Human Molecular Genetics. 16(22). 2760–2769. 15 indexed citations

19.

Hall, Gerri S., et al.. (2001). Case of Synovitis Potentially Caused by Dolosigranulum pigrum. Journal of Clinical Microbiology. 39(3). 1202–1203. 18 indexed citations

20.

Anthony, Karen, et al.. (1995). Bacillary angiomatosis of the skin and bone marrow in a patient with HIV infection. Journal of the American Academy of Dermatology. 32(3). 510–512. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact